Clover Biopharmaceuticals Ltd Sustainability Reports
Clover Biopharmaceuticals, Ltd. is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative vaccines. The company leverages its proprietary Trimer-Tag technology platform to build a franchise targeting respiratory and infectious diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG0135F03V2
6 reports from 2021 to 2025
